Patents by Inventor Bernadette Pignol

Bernadette Pignol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Autonomic Disorders with Botulinum Toxin
    Publication number: 20200377872
    Abstract: The present invention relates to the treatment of autonomic disorders with a clostridial neurotoxin comprising a HCC domain from a BoNT/B, BoNT/D, BoNT/D-C, BoNT/F or BoNT/G, wherein the dose of the clostridial neurotoxin to be administered to the patient is equivalent to or lower than the dose of BoNT/A that would be used to treat the same autonomic disorder.
    Type: Application
    Filed: December 20, 2018
    Publication date: December 3, 2020
    Inventors: Johannes KRUPP, Jacquie MAIGNEL-LUDOL, Bernadette PIGNOL
  • Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament
    Patent number: 8642591
    Abstract: The present invention relates to a composition containing at least one amidine derivative or carboxamide derivative of general formula (I) or (A) in combination with at least one compound chosen from steroids, corticoids or corticosteroids, wherein said composition is suitable for the preparation of a medicament.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: February 4, 2014
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Bernadette Pignol, Serge Auvin, Dennis Bigg, Pierre-Etienne Chabrier de Lassauniere
  • Use of a phenothiazine derivative for preventing and/or treating hearing loss
    Patent number: 7696197
    Abstract: The invention concerns the use of a phenothiazine derivative of formula (I), wherein: R represents the hydrogen atom, an alkyl radical, arylalkyl, or —C(O)R?, for preparing a medicine for preventing and/or treating hearing loss.
    Type: Grant
    Filed: March 25, 2005
    Date of Patent: April 13, 2010
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques
    Inventors: Bernadette Pignol, Jean-Luc Puel, Serge Auvin, Pierre-Entienne Chabrier de Lassauniere, Jing Wang
  • Amidine derivatives and their applications as a medicament
    Patent number: 7659266
    Abstract: The invention concerns amidine derivatives of general formula (I) exhibiting an inhibitory activity of calpains and/or a trapping activity of reactive forms of oxygen.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: February 9, 2010
    Assignee: S.C.R.A.S.
    Inventors: Serge Auvin, Dennis Bigg, Pierre-Etienne Chabrier De Lassauniere, Bernadette Pignol
  • COMPOSITION CONTAINING AMIDINE DERIVATIVES OR CARBOXAMIDE DERIVATIVES AND STEROIDS, AS A MEDICAMENT
    Publication number: 20090149430
    Abstract: The present invention relates to a composition containing at least one amidine derivative or carboxamide derivative of general formula (I) or (A) in combination with at least one compound chosen from steroids, corticoids or corticosteroids, wherein said composition is suitable for the preparation of a medicament.
    Type: Application
    Filed: March 6, 2007
    Publication date: June 11, 2009
    Inventors: Bernadette Pignol, Serge Auvin, Dennis Bigg, Pierre-Etienne Chabrier De Lassauniere
  • AMIDINE DERIVATIVES AND THEIR APPLICATIONS AS A MEDICAMENT
    Publication number: 20090018120
    Abstract: The invention concerns amidine derivatives of general formula (I) exhibiting an inhibitory activity of calpains and/or a trapping activity of reactive forms of oxygen.
    Type: Application
    Filed: October 18, 2006
    Publication date: January 15, 2009
    Applicant: Societe de Conseils de Recherches et D'Applications Scientifiques
    Inventors: Serge Auvin, Dennis Bigg, Pierre-Etienne Chabrier De Lassauniere, Bernadette Pignol
  • Use of a Phenothiazine Derivative for Preventing and/or Treating Hearing Loss
    Publication number: 20080275034
    Abstract: The invention concerns the use of a phenothiazine derivative of formula (I), wherein: R represents the hydrogen atom, an alkyl radical, arylalkyl, or —C(O)R?, for preparing a medicine for preventing and/or treating hearing loss.
    Type: Application
    Filed: March 25, 2005
    Publication date: November 6, 2008
    Applicant: Societe de Conseils de Recherches et
    Inventors: Bernadette Pignol, Jean-Luc Puel, Serge Auvin, Pierre-Etierne Chabrier de Lassauniere, Jing Wang
  • Association of calpain inhibitors and reactive oxygen species trapping agents
    Publication number: 20070265208
    Abstract: A pharmaceutical composition comprising, as active ingredient, at least one calpain inhibitor substance and at least one reactive oxygen species trapping substance, and optionally a pharmaceutically acceptable support.
    Type: Application
    Filed: June 1, 2007
    Publication date: November 15, 2007
    Inventors: Pierre-Etienne Chabrier de Lassauniere, Bernadette Pignol, Serge Auvin
  • Association of calpain inhibitors and reactive oxygen species trapping agents
    Patent number: 7244711
    Abstract: The invention concerns a pharmaceutical composition comprising, as active principle, at least a calpain inhibiting substance and at least a substance trapping reactive oxygen species (ROS), and optionally an acceptable pharmaceutical carrier. The invention also concerns a product comprising at least a calpain inhibiting substance and at least a substance trapping reactive oxygen species (ROS), selectively or not, as combination product, the active principle being separate.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: July 17, 2007
    Assignee: Societe de Conseils de Recherches et d' 'Applications Scientifiques S.C.R.A.S
    Inventors: Pierre-Etienne Chabrier de Lassauniere, Bernadette Pignol, Serge Auvin
  • Association of calpain inhibitors and reactive oxygen species trapping agents
    Publication number: 20040053851
    Abstract: The invention concerns a pharmaceutical composition comprising, as active principle, at least a calpain inhibiting substance and at least a substance trapping reactive oxygen species (ROS), and optionally an acceptable pharmaceutical carrier. The invention also concerns a product comprising at least a calpain inhibiting substance and at least a substance trapping reactive oxygen species (ROS), selectively or not, as combination product, the active principle being separate.
    Type: Application
    Filed: April 30, 2003
    Publication date: March 18, 2004
    Inventors: Pierre-Etienne Chabrier de Lassauniere, Bernadette Pignol, Serge Auvin